Schrödinger, Inc. (SDGR)

Market Cap	868.18M -39.1%
Revenue (ttm)	255.87M +23.3%
Net Income	-103.27M
EPS	-1.41
Shares Out	73.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,173,832
Open	11.77
Previous Close	11.79
Day's Range	11.73 - 12.25
52-Week Range	10.95 - 27.63
Beta	1.62
Analysts	Buy
Price Target	21.00 (+78.57%)
Earnings Date	May 5, 2026

About SDGR

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and cli...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Feb 6, 2020
• Employees: 850
• Stock Exchange: NASDAQ
• Ticker Symbol: SDGR
• Website: https://www.schrodinger.com

Financial Performance

In 2025, Schrödinger's revenue was $255.87 million, an increase of 23.29% compared to the previous year's $207.54 million. Losses were -$103.27 million, -44.81% less than in 2024.

Analyst Summary

According to 9 analysts, the average rating for SDGR stock is "Buy." The 12-month stock price target is $21.0, which is an increase of 78.57% from the latest price.

Price Target

$21.0

(78.57% upside)

Analyst Consensus: Buy